<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="eclaire-study-phase-source-code-system"/>
  <meta>
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablecodesystem"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Narratif généré : CodeSystem eclaire-study-phase-source-code-system</b></p><a name="eclaire-study-phase-source-code-system"> </a><a name="hceclaire-study-phase-source-code-system"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profil: <a href="http://hl7.org/fhir/R4/shareablecodesystem.html">Shareable CodeSystem</a></p></div><p>This case-sensitive code system <code>https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">jarde-early<a name="eclaire-study-phase-source-code-system-jarde-early"> </a></td><td>Jardé phase précoce</td></tr><tr><td style="white-space:nowrap">phase-I-first-admin<a name="eclaire-study-phase-source-code-system-phase-I-first-admin"> </a></td><td>Human Pharmacology (Phase I) - First administration to humans</td></tr><tr><td style="white-space:nowrap">phase-I-bioequivalence<a name="eclaire-study-phase-source-code-system-phase-I-bioequivalence"> </a></td><td>Human Pharmacology (Phase I) - Bioequivalence Study</td></tr><tr><td style="white-space:nowrap">phase-I-other<a name="eclaire-study-phase-source-code-system-phase-I-other"> </a></td><td>Human Pharmacology (Phase I) -  Other</td></tr><tr><td style="white-space:nowrap">phase-I-II-first-admin<a name="eclaire-study-phase-source-code-system-phase-I-II-first-admin"> </a></td><td>Phase I and Phase II (Integrated) - First administration to humans</td></tr><tr><td style="white-space:nowrap">phase-I-II-first-bioequivalence<a name="eclaire-study-phase-source-code-system-phase-I-II-first-bioequivalence"> </a></td><td>Phase I and Phase II (Integrated) - Bioequivalence Study</td></tr><tr><td style="white-space:nowrap">phase-I-II-other<a name="eclaire-study-phase-source-code-system-phase-I-II-other"> </a></td><td>Phase I and Phase II (Integrated) - Other</td></tr><tr><td style="white-space:nowrap">phase-II<a name="eclaire-study-phase-source-code-system-phase-II"> </a></td><td>Therapeutic exploratory (Phase II)</td></tr><tr><td style="white-space:nowrap">phase-II-III<a name="eclaire-study-phase-source-code-system-phase-II-III"> </a></td><td>Phase II and Phase III (Integrated)</td></tr><tr><td style="white-space:nowrap">phase-III<a name="eclaire-study-phase-source-code-system-phase-III"> </a></td><td>Therapeutic confirmatory  (Phase III)</td></tr><tr><td style="white-space:nowrap">phase-IV<a name="eclaire-study-phase-source-code-system-phase-IV"> </a></td><td>Therapeutic use (Phase IV)</td></tr><tr><td style="white-space:nowrap">phase-III-IV<a name="eclaire-study-phase-source-code-system-phase-III-IV"> </a></td><td>Phase III and phase IV (Integrated)</td></tr></table></div>
  </text>
  <url value="https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system"/>
  <version value="0.3.1"/>
  <name value="EclaireStudyPhaseSourceCS"/>
  <title value="Définition des phase de l'essai utilisés dans la base de données ECLAIRE"/>
  <status value="draft"/>
  <experimental value="true"/>
  <date value="2025-07-23T15:19:40+00:00"/>
  <publisher value="ANS"/>
  <contact>
    <name value="ANS"/>
    <telecom>
      <system value="url"/>
      <value value="https://esante.gouv.fr"/>
    </telecom>
  </contact>
  <description value="Définition des phases de l'essai utilisées dans la base de données ECLAIRE"/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="FR"/>
      <display value="FRANCE"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <compositional value="false"/>
  <content value="complete"/>
  <count value="12"/>
  <concept>
    <code value="jarde-early"/>
    <display value="Jardé phase précoce"/>
  </concept>
  <concept>
    <code value="phase-I-first-admin"/>
    <display value="Human Pharmacology (Phase I) - First administration to humans"/>
  </concept>
  <concept>
    <code value="phase-I-bioequivalence"/>
    <display value="Human Pharmacology (Phase I) - Bioequivalence Study"/>
  </concept>
  <concept>
    <code value="phase-I-other"/>
    <display value="Human Pharmacology (Phase I) -  Other"/>
  </concept>
  <concept>
    <code value="phase-I-II-first-admin"/>
    <display value="Phase I and Phase II (Integrated) - First administration to humans"/>
  </concept>
  <concept>
    <code value="phase-I-II-first-bioequivalence"/>
    <display value="Phase I and Phase II (Integrated) - Bioequivalence Study"/>
  </concept>
  <concept>
    <code value="phase-I-II-other"/>
    <display value="Phase I and Phase II (Integrated) - Other"/>
  </concept>
  <concept>
    <code value="phase-II"/>
    <display value="Therapeutic exploratory (Phase II)"/>
  </concept>
  <concept>
    <code value="phase-II-III"/>
    <display value="Phase II and Phase III (Integrated)"/>
  </concept>
  <concept>
    <code value="phase-III"/>
    <display value="Therapeutic confirmatory  (Phase III)"/>
  </concept>
  <concept>
    <code value="phase-IV"/>
    <display value="Therapeutic use (Phase IV)"/>
  </concept>
  <concept>
    <code value="phase-III-IV"/>
    <display value="Phase III and phase IV (Integrated)"/>
  </concept>
</CodeSystem>